Candida krusei fungemia: An escalating serious infection in immunocompromised patients

Archives of Internal Medicine

Volumn 160, Issue 17, 2000, Pages 2659-2664

  Abbas, Jalal ^a   Bodey, Gerald P ^a   Hanna, Hend A ^a   Mardani, Masoud ^a   Girgawy, Essam ^a   Abi Said, Dima ^a   Whimbey, Estella ^a   Hachem, Ray ^a   Raad, Issam ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CONTROLLED STUDY; FEMALE; FUNGEMIA; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 0034715262     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.17.2659     Document Type: Article

References (22)

1. Importance of Candida species other than C albicans as pathogens in oncology patients
2. The epidemiology of hematogenous candidiasis caused by different Candida species
3. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome
4. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy
5. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
6. Candida krusei fungemia: Report of 4 cases and review of the literature
7. Predictors of adverse outcome in cancer patients with candidemia
8. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy
9. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
10. Increased incidence of fungemia caused by Candida krusei
11. Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole
12. Fluconazole prophylaxis of fungal infection in patients with acute leukemia: Results of randomized placebo-controlled, double-blind, multicenter trial
13. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
14. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: A prospective, randomized, double-blind study
15. Hematogenous and major organ candidiasis
16. Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation
17. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method
18. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients with candidemia
19. Strain variation among and antifungal susceptibilities of isolates of Candida krusei
20. Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer
21. Itraconazole cyclodextrin solution: The role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidiasis